FDA Approves First Therapy for Allergic Fungal Rhinosinusitis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 2 min

Share

Original Source(s)

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

  • by Kathryn Wighton

  • February 25, 2026

Related Content

Case Report: ACTH-independent Cushing’s syndrome caused by isolated micronodular adrenal disease in a 23-month-old girl

Effects of exercise interventions on executive function in autism spectrum disorder: a three-level meta-analytic review

Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy